Skip to content

CTEV CTEV Change in Accrued Liabilities

Change in Accrued Liabilities at other companies

Evolent Health, Inc. logo
Evolent Health, Inc.EVH
-$20.98M-11.1%
Corvel logo
CorvelCRVL
$13.23M+830%
Phreesia logo
PhreesiaPHR
-$6.99M-684%
ROP
Roper Technologies, Inc.ROP
-$94.9M+11.6%
IQVIA logo
IQVIAIQV
-$74.75M-92.9%
Omnicell logo
OmnicellOMCL
-$292K-121%

Other financials

Income statement

See full
Revenue$244.7M+5.8%
Gross profit$175.6M+2.8%
Operating income$6.6M-31.9%
Net income-$73.6M-3.1%
EPS (diluted)-$4.41-0.7%

Balance sheet

See full
Cash & equivalents$34.7M+2.4%
Total debt$4.7B+1.1%
Total equity-$241.1M-1,727%
Total assets$4.8B-4.8%

Cash flow

See full
Operating cash flow-$45.8M-52.3%
CapEx$46.8M+20.3%
Free cash flow-$92.5M-34.3%

Valuation

See full
Market cap$591.9M-10.0%
Enterprise value$5.22B
P/S0.6×

Profitability

See full
Gross margin73.2%-0.9pp
Operating margin-0.5%-0.3pp
Net margin-29.3%-12.7pp
FCF margin-10.6%

Returns & leverage

See full
Return on equity-198.7%-274pp
Debt / equity310.9×+307×
Current ratio1.3×+0.3×

Where this comes from

Reported directly by CTEV in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInOtherAccruedLiabilities.

The official record: CTEV’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about CTEV's change in accrued liabilities.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is CTEV's change in accrued liabilities?
CTEV (CTEV) reported change in accrued liabilities of -$69.51M in Q1 2026.
How has CTEV's change in accrued liabilities changed year-over-year?
CTEV's change in accrued liabilities decreased by 561.1% year-over-year, from $15.07M to -$69.51M.
What does change in accrued liabilities mean?
Change in accrued expenses and other current liabilities, reflecting timing differences between expense recognition and cash payment.